Recurrence · adults with basal cell carcinoma of the skin
MAL‐PDT may leads to higher recurrence at 3 years compared with surgical excision (low certainty).
1 finding from 1 review
Cosmesis · adults with basal cell carcinoma of the skin
MAL‐PDT probably leads to higher cosmetic outcome (excellent/good) compared with surgical excision (moderate certainty).
1 finding from 1 review
Pain · adults with basal cell carcinoma of the skin
MAL‐PDT showed no clear difference in pain compared with surgical excision (low certainty).
1 finding from 1 review
Early treatment failure · adults with basal cell carcinoma of the skin
MAL‐PDT probably leads to higher early treatment failure compared with surgical excision (moderate certainty).
1 finding from 1 review
Investigator's global assessment (IGA) of improvement Treatment 'success' as defined by IGA score decrease5 · Moderate and severe acne vulgaris
MAL‐PDT probably leads to higher investigator's global assessment (IGA) of improvement Treatment… compared with red light only (moderate certainty).
1 finding from 1 review
Paticipant's global assessment of improvement ‐ Not measured · Moderate and severe acne vulgaris
The review found no eligible studies for this question.
1 finding from 1 review
Light therapies for acne 2016 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Investigator‐assessed change in inflamed lesions (ILs) Lesion counts · Moderate and severe acne vulgaris
1 finding from 1 review
Investigator‐assessed change in non‐inflamed lesions (NILs) Lesion counts · Moderate and severe acne vulgaris
1 finding from 1 review
Investigator‐assessed percentage change in ILs Lesion counts · Moderate and severe acne vulgaris
1 finding from 1 review
Investigator‐assessed percentage change in NILs Lesion counts · Moderate and severe acne vulgaris
1 finding from 1 review
Investigator‐assessed severe adverse effects Application site blister · Moderate and severe acne vulgaris
1 finding from 1 review
Recurrence · adults with basal cell carcinoma of the skin
Imiquimod cream probably leads to lower recurrence at 3 years compared with MAL‐PDT (moderate certainty).
2 findings from 1 review
Cosmesis · adults with basal cell carcinoma of the skin
Imiquimod cream showed no clear difference in cosmetic outcome (excellent/good) compared with MAL‐PDT (moderate certainty).
1 finding from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · adults with basal cell carcinoma of the skin
Imiquimod cream probably leads to lower pain (moderate/severe) compared with MAL‐PDT (moderate certainty).
1 finding from 1 review
Early treatment failure · adults with basal cell carcinoma of the skin
Imiquimod cream showed no clear difference in early treatment failure compared with MAL‐PDT (moderate certainty).
1 finding from 1 review